Saroglitazar, CAS 495399-09-2

Product Description: Saroglitazar is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively.

Applications: Metabolism-sugar/lipid metabolism

Formula: C25H29NO4S

Citations: Cell Biol Toxicol. 2020 Jul 1. /Patent. US20190388398A1./SSRN. 2024 May 30./BMC Complement Med Ther. 2021 Apr 10;21(1):118./Patent. US20210275504A1.

References: [1]Jain MR, et al. Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models. Pharmacol Res Perspect. 2015 Jun;3(3):e00136.

CAS Number: 495399-09-2

Molecular Weight: 439.57

Compound Purity: 99.10

Research Area: Metabolic Disease

Solubility: DMSO : ≥ 25 mg/mL

Target: PPAR

• SKU: MEXHY-19937-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-19937-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK